
No. of Pages: 82 | Report Code: BMIRE00029271 | Category: Life Sciences
No. of Pages: 82 | Report Code: BMIRE00029271 | Category: Life Sciences
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South & Central America Glioma Treatment Market - Key Industry Dynamics
4.1 Market Drivers
4.1.1 High Incidence Rate of Brain Cancer in South America
4.1.2 Increase in Prevalence of High-Grade Glioma
4.2 Key Market Restraints
4.2.1 High Cost of Diagnosis
4.3 Key Market Opportunities
4.3.1 Advancements in Healthcare Sector in Emerging Economies
4.4 Future Trends
4.4.1 Surge in Drug Approvals for Glioma Treatment
4.5 Impact Analysis:
5. Glioma Treatment Market - South & Central America Market Analysis
5.1 South & Central America Glioma Treatment Market Revenue (US$ Mn), 2022 - 2030
6. South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 - by Disease
6.1 Overview
6.2 South & Central America Glioma Treatment Market Revenue Share, by Disease 2022 & 2030 (%)
6.3 Astrocytoma
6.3.1 Overview
6.3.2 Astrocytoma: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Oligoastrocytoma
6.4.1 Overview
6.4.2 Oligoastrocytoma: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Oligodendroglioma
6.5.1 Overview
6.5.2 Oligodendroglioma: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7. South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 - by Treatment Type
7.1 Overview
7.2 South & Central America Glioma Treatment Market Revenue Share, by Treatment Type 2022 & 2030 (%)
7.3 Surgery
7.3.1 Overview
7.3.2 Surgery: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Chemotherapy
7.4.1 Overview
7.4.2 Chemotherapy: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Radiation Therapy
7.5.1 Overview
7.5.2 Radiation Therapy: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8. South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 - by Grade
8.1 Overview
8.2 South & Central America Glioma Treatment Market Revenue Share, by Grade 2022 & 2030 (%)
8.3 Low Grade
8.3.1 Overview
8.3.2 Low Grade: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.3.2.1 Grade I: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.3.2.2 Grade II: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.4 High Grade
8.4.1 Overview
8.4.2 High Grade: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.4.2.1 Grade III: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.4.2.2 Grade IV: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
9. South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 - by End User
9.1 Overview
9.2 South & Central America Glioma Treatment Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Hospital & Clinics
9.3.1 Overview
9.3.2 Hospital & Clinics: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Ambulatory Surgical Centers
9.4.1 Overview
9.4.2 Ambulatory Surgical Centers: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
10. South & Central America Glioma Treatment Market - Country Analysis
10.1 South & Central America Glioma Treatment Market, Revenue and Forecast to 2030
10.1.1 Overview
10.1.1.1 South & Central America Glioma Treatment Market, by Country
10.1.1.2 Brazil
10.1.1.2.1 Brazil: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.2.2 Brazil: South & Central America Glioma Treatment Market, by Disease
10.1.1.2.3 Brazil: South & Central America Glioma Treatment Market, by Treatment Type
10.1.1.2.4 Brazil: South & Central America Glioma Treatment Market, by Grade
10.1.1.2.4.1 Brazil: South & Central America Glioma Treatment Market, by Low Grade
10.1.1.2.4.2 Brazil: South & Central America Glioma Treatment Market, by High Grade
10.1.1.2.5 Brazil: South & Central America Glioma Treatment Market, by End User
10.1.1.3 Argentina
10.1.1.3.1 Argentina: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.3.2 Argentina: South & Central America Glioma Treatment Market, by Disease
10.1.1.3.3 Argentina: South & Central America Glioma Treatment Market, by Treatment Type
10.1.1.3.4 Argentina: South & Central America Glioma Treatment Market, by Grade
10.1.1.3.4.1 Argentina: South & Central America Glioma Treatment Market, by Low Grade
10.1.1.3.4.2 Argentina: South & Central America Glioma Treatment Market, by High Grade
10.1.1.3.5 Argentina: South & Central America Glioma Treatment Market, by End User
10.1.1.4 Rest of South & Central America
10.1.1.4.1 Rest of South & Central America: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
10.1.1.4.2 Rest of South & Central America: South & Central America Glioma Treatment Market, by Disease
10.1.1.4.3 Rest of South & Central America: South & Central America Glioma Treatment Market, by Treatment Type
10.1.1.4.4 Rest of South & Central America: South & Central America Glioma Treatment Market, by Grade
10.1.1.4.4.1 Rest of South & Central America: South & Central America Glioma Treatment Market, by Low Grade
10.1.1.4.4.2 Rest of South & Central America: South & Central America Glioma Treatment Market, by High Grade
10.1.1.4.5 Rest of South & Central America: South & Central America Glioma Treatment Market, by End User
11. Glioma Treatment Market Industry Landscape
11.1 Overview
11.2 Growth Strategies Done by the Companies in the Market, (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12. Company Profiles
12.1 F. Hoffmann-La Roche Ltd
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Merck & Co Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Sun Pharmaceutical Industries Ltd
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Amgen Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Teva Pharmaceutical Industries Ltd
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Pfizer Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Biocon Ltd
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms
List of Tables
Table 1. South & Central America Glioma Treatment Market Segmentation
Table 2. Brazil: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
Table 3. Brazil: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
Table 4. Brazil: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
Table 5. Brazil: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
Table 6. Brazil: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
Table 7. Brazil: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
Table 8. Argentina: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
Table 9. Argentina: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
Table 10. Argentina: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
Table 11. Argentina: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Low Grade
Table 12. Argentina: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - High Grade
Table 13. Argentina: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
Table 14. Rest of South & Central America: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
Table 15. Rest of South & Central America: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
Table 16. Rest of South & Central America: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
Table 17. Rest of South & Central America: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
Table 18. Rest of South & Central America: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
Table 19. Rest of South & Central America: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
Table 20. Organic Developments Done By Companies
Table 21. Inorganic Developments Done By Companies
Table 22. Glossary of Terms, glioma treatment market
List of Figures
Figure 1. South & Central America Glioma Treatment Market Segmentation, By Country
Figure 2. South & Central America Glioma Treatment Market - Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. South & Central America Glioma Treatment Market Revenue (US$ Mn), 2022 - 2030
Figure 5. South & Central America Glioma Treatment Market Revenue Share, by Disease 2022 & 2030 (%)
Figure 6. Astrocytoma: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Oligoastrocytoma: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Oligodendroglioma: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. South & Central America Glioma Treatment Market Revenue Share, by Treatment Type 2022 & 2030 (%)
Figure 10. Surgery: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Chemotherapy: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Radiation Therapy: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Others: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. South & Central America Glioma Treatment Market Revenue Share, by Grade 2022 & 2030 (%)
Figure 15. Low Grade: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Grade I: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Grade II: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. High Grade: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Grade III: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Grade IV: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. South & Central America Glioma Treatment Market Revenue Share, by End User 2022 & 2030 (%)
Figure 22. Hospital & Clinics: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Ambulatory Surgical Centers: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. South & Central America Glioma Treatment Market, By Country, 2022 ($Mn)
Figure 25. South & Central America Glioma Treatment Market, By Key Countries, 2022 And 2030 (%)
Figure 26. Brazil: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 27. Argentina: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 28. Rest of South & Central America: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 29. Growth Strategies Done by the Companies in the Market, (%)
1. Amgen Inc
2. Biocon Ltd
3. F. Hoffmann-La Roche Ltd
4. Merck & Co Inc
5. Pfizer Inc
6. Sun Pharmaceutical Industries Ltd
7. Teva Pharmaceutical Industries Ltd